QSA's Week in BioPharma (#9, 2024)
Aramis Biotechnologies secures $40M; Alberta drug access deal; PMPRB report release; R&D spending climbs; CEPA waivers for biopharma.
Start Date: 2024-11-30
End Date: 2024-12-06
Top Headlines
Main Stories
Government Invests $40 Million in Aramis Biotechnologies
The Government of Canada announced a $40 million investment through the Strategic Innovation Fund to support Aramis Biotechnologies in developing plant-based vaccines and therapeutics. This initiative is set to create at least 80 jobs and build on the technology platform previously developed by Medicago, a former Quebec-based company. This investment is part of Canada's Biomanufacturing and Life Sciences Strategy, aiming to strengthen domestic vaccine production capabilities.
Sources: ['Announcements: www.canada.ca']
